Hoping Chinese Itrack Advance approval soon.
With more impressive data coming through in the treatment of closed angle glaucoma EYE could see some rapid uptake in China.
Another potential catalyst to look forward to.
Hoping Chinese Itrack Advance approval soon.With more impressive...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.015(5.36%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 26.0¢ | $156.5K | 580.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 81682 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 40706 | 2 |
View Market Depth
| Last trade - 16.10pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.5¢ |
Change
-0.015 ( 5.36 %) |
||||
| Open | High | Low | Volume | ||
| 27.5¢ | 27.5¢ | 26.5¢ | 251435 | ||
| Last updated 15.58pm 23/05/2024 ? | |||||
| EYE (ASX) Chart |